Supported By
"RSN continues to serve the kidney community by instilling health, happiness, and hope through education, advocacy, and awareness... one person at a time." Thank you for your support of our mission.
Abbott has been in the business of improving lives for more than a century. Our 60,000 employees around the world are dedicated to discovering, developing, and marketing innovative health care solutions across the spectrum of health care. Abbott markets pharmaceuticals to the renal community. Abbott is dedicated to producing quality products and services focused upon diseases of the kidney. They produce Zemplar Capsules (Paricalcitol Injection), a vitamin D analog. Their team of sales and clinical specialist are available to assist you with your product and clinical education needs. For further information visit www.zemplar.com.
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.
Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology, and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.
To learn more about our pioneering science and our vital medicines, visit www.amgen.com.
Astellas and its affiliated US entities, subsidiaries of Tokyo-based Astellas Pharma, Inc., are a research-based pharmaceutical company dedicated to improving the health of people around the world through innovative pharmaceutical products. Astellas has been dedicated to the field of immunology for nearly twenty years and is the leader in transplantation. Astellas ranks among the top 20 pharmaceutical companies in the world and will continue to grow as a competitive company in the world pharmaceutical market. For more information on Astellas, please go to www.astellas.us or www.transplantexperience.com.
DaVita provides dialysis services for those diagnosed with chronic kidney failure, a condition also known as chronic kidney disease (CKD). We have over 1,809 outpatient dialysis facilities and acute units in over 700 hospitals. We are located in 43 states and the District of Columbia, serving approximately 142,000 patients.
The name DaVita is an adaptation of an Italian phrase meaning, “giving life.” Everyday, in all of our clinics, we believe our name reflects our purpose. Please learn more by visiting www.davita.com.
Fresenius Medical Care North America (FMCNA) is the nation’s leading integrated provider of products and services for individuals with chronic kidney failure, a condition that affects nearly 400,000 Americans, and more than 1,400,000 individuals worldwide. With more than 35,000 employees, FMCNA operates a nationwide network of clinics that provide dialysis treatment. The company also manufactures and distributes dialysis products, performs specialized diagnostic and laboratory testing for renal patients, and provides comprehensive renal disease management services. With corporate offices in Massachusetts, the company is the largest affiliate of German-based Fresenius Medical Care AG, which is in turn the world’s largest provider of products and services for individuals with chronic renal failure. The roots of the company’s Fresenius Medical Services division stem back to1970 when the company opened one of the first outpatient dialysis clinics in the world, in Boston. This was the advent of the availability of dialysis services outside of the cost and space limitations of the hospital environment and has led to more widespread access to this life-sustaining treatment nationwide. Visit www.ultracare-dialysis.com or www.kidneyoptions.com for more information.
Genentech, considered the founder of the biotechnology industry, has been delivering on the promise of biotechnology for more than 35 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. Visit www.gene.com for more information.
NRAA is a nonprofit organization representing independent, regional and community based dialysis providers throughout the United States. NRAA members include renal administrators, nurse managers, nurses, medical directors, technicians and financial/billing managers for dialysis clinics, which provide life-sustaining dialysis care to the majority of Medicare End Stage Renal Disease (ESRD) patients. From a few charter members in 1977, NRAA has become the respected leader in the dialysis community representing the operational concerns of dialysis facilities. Through education, networking, collaboration and legislative advocacy, NRAA strives to support clinical and financial best practices while enhancing professionalism throughout the kidney community. Call 215-320-4655 or visit www.nraa.org for more information.
NxStage® Medical Inc., is a medical device company headquartered in Lawrence, MA, that develops, manufactures, and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Over 5,000 home patients enjoy the freedom and flexibility of the System One™ hemodialysis machine, the first truly portable system indicated for home hemodialysis. In hospital ICUs, NxStage is the equipment of choice for 8 of the top 10 kidney disease hospitals (as ranked by US News & World Report). Medisystems, a NxStage company, is the market leader in tubing and access needle products in US dialysis centers. Visit http://www.nxstage.com/ for more information.
OneLegacy saves and heals lives through organ, eye and tissue donation, comforts the families we serve, and inspires our communities to Donate Life. OneLegacy proudly serves the 11 transplant centers, 200 hospitals, and diverse population of 19 million people in Los Angeles, Kern, Orange, Riverside, San Bernardino, Santa Barbara and Ventura counties. For more information, please visit www.onelegacy.org.
Sanofi, (Genzyme is a subsidary of Sanofi) a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Visit http://en.sanofi.com/ for more information.